Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc - 2:23-cv-03530

Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc (Case No. 2:23-cv-03530), filed on Jun 29, 2023 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
2:23-cv-03530
Filing Date
Jun 29, 2023
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD. -
BOEHRINGER INGELHEIM INTERNATIONAL GMBH -
ANOBRI PHARMACEUTICALS US, LLC -
NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

Docket entries not found - set an alert to get notified when docket entries are added.